Donoghue Forlines’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-456
| Closed | -$375K | – | 271 |
|
|
2023
Q1 | $375K | Sell |
456
-45
| -9% | -$37K | 0.13% | 173 |
|
|
2022
Q4 | $361K | Sell |
501
-208
| -29% | -$150K | 0.13% | 183 |
|
|
2022
Q3 | $488K | Sell |
709
-1,616
| -70% | -$1.11M | 0.18% | 103 |
|
|
2022
Q2 | $1.37M | Buy |
2,325
+1,091
| +88% | +$645K | 0.36% | 54 |
|
|
2022
Q1 | $862K | Buy |
+1,234
| New | +$862K | 0.19% | 175 |
|
|
2020
Q3 | – | Sell |
-2,308
| Closed | -$1.44M | – | 137 |
|
|
2020
Q2 | $1.44M | Buy |
+2,308
| New | +$1.44M | 0.38% | 43 |
|
|
2019
Q2 | – | Sell |
-6,604
| Closed | -$2.71M | – | 205 |
|
|
2019
Q1 | $2.71M | Buy |
+6,604
| New | +$2.71M | 0.27% | 57 |
|
|
2018
Q4 | – | Sell |
-6,631
| Closed | -$2.68M | – | 124 |
|
|
2018
Q3 | $2.68M | Buy |
+6,631
| New | +$2.68M | 0.21% | 82 |
|